Definitive Contract 75N93024C00062
Award Date
9/10/24
Potential Completion Date
9/9/25
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Tolka.ai Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33136, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to Teichos Laboratories, LLC, a small business located in West Lafayette, IN. The $300,000 firm fixed price contract is for research on a novel TLR2 agonist-aluminum combination adjuvant to improve the quality and duration of the immune response. This SBIR contract was awarded under a solicitation that sought innovative...
The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This firm fixed price definitive contract for $300,000 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Innov8Ai, a for-profit small business, to advance the agency's mission through research and development. The contract is associated with the Small Business Innovation Research Program Phase I solicitation to capture medical misinformation in social media for targeted interdiction using an...
This is a $599,234 firm fixed price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Celdara Medical, a small business biotechnology company, under the Small Business Innovation Research (SBIR) program. The contract is for research to discover parasite-derived tolerogenic adjuvants, which could potentially be used in new vaccine development. Celdara Medical conducts research and...
This federal contract award, valued at $224,562.96, was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health (NIH). The contract was awarded to Infotech Soft, Inc., a for-profit, woman-owned business, and is a Definitive Contract with a Firm Fixed Price. The work is to be performed in Miami, Florida and the contract has a completion date of July 31, 2018. This appears to be a...
This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and...
This is a $299,208 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to John Snow Labs Inc., a self-certified small disadvantaged business. The contract is for SBIR Topic 135, with a period of performance through September 4, 2025. The contract does not have a set-aside designation. As an SBIR (Small Business Innovation Research) contract, it is part of a larger SBIR program managed by NIAID to fund research and...